Taxus Pharma
Latest round
- Series B
Last raised
- Apr 2022
Total raised
- Undisclosed
Investors
- 4
About Taxus Pharma
Founded in 2004 and based in Wuxi, China, Taxus Pharma is a pharmaceutical company that provides antineoplastic drugs. In 2022, the company was listed on the National Equities Exchange and Quotations. Its stock code is 873858.03% of a minority stake in the company. Taxus Pharma belongs to Hongdou Group. The company's main products include calcium folate, paclitaxel injection and allopurinol, etc. Paclitaxel injection is used in the first-line and second-line treatment of ovarian cancer, breast cancer and non-small cell lung cancer (NSCLC).
Who invested in Taxus Pharma
4 investors across 1 round
See all investors in Taxus Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 29, 2022
Amount
Undisclosed
Investors
Questions about Taxus Pharma
Who invested in Taxus Pharma?
Taxus Pharma has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Taxus Pharma raised?
Taxus Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Taxus Pharma last raise money?
Taxus Pharma's most recent round on record is a Series B, in Apr 2022.
What does Taxus Pharma do?
Founded in 2004 and based in Wuxi, China, Taxus Pharma is a pharmaceutical company that provides antineoplastic drugs.
Where is Taxus Pharma headquartered?
Taxus Pharma is headquartered in Wuxi, China.
Which VCs invest in companies like Taxus Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Taxus Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Taxus Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.